Dataset Information

Immune checkpoint inhibitors win the 2018 Nobel Prize.

ABSTRACT: The 2018 Nobel Prize in Physiology or Medicine was awarded to Tasuku Honjo and James Allison for their discoveries in cancer immunology. Professor Honjo was awarded due to his discovery of the programmed death molecule-1 (PD-1) on T cells. Professor Allison discovered another important immunosuppressive molecule: cytotoxic T-lymphocyte antigen-4 (CTLA-4). Suppression of T cell activation by PD-1 and/or CTLA-4 is considered one of the major escape mechanisms of cancer cells. Inhibition of these molecules by immune checkpoint inhibitors can successfully activate the immune system to fight cancer. Checkpoint inhibitors have brought about a major breakthrough in cancer immunotherapy, reviving the hope of curing patients with end-stage cancer, including a wide variety of cancer types. In metastatic malignant melanoma, the previous long-term survival of only 5% can now be extended to 50% with anti-PD-1 plus anti-CTLA-4 combined treatment in the latest report. More checkpoint molecules such as lymphocyte-activation gene 3 and T cell immunoglobulin and mucin domain 3 are under investigation. The achievement of Drs. Honjo and Allison in cancer immunotherapy has encouraged research into other immune-pathological diseases.

SUBMITTER: Huang PW

PROVIDER: S-EPMC6889239 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Immune checkpoint inhibitors win the 2018 Nobel Prize.

Huang Pei-Wei PW Chang John Wen-Cheng JW

Biomedical journal 20191001 5

The 2018 Nobel Prize in Physiology or Medicine was awarded to Tasuku Honjo and James Allison for their discoveries in cancer immunology. Professor Honjo was awarded due to his discovery of the programmed death molecule-1 (PD-1) on T cells. Professor Allison discovered another important immunosuppressive molecule: cytotoxic T-lymphocyte antigen-4 (CTLA-4). Suppression of T cell activation by PD-1 and/or CTLA-4 is considered one of the major escape mechanisms of cancer cells. Inhibition of these m ...[more]

PMID: 31783990

Similar Datasets

Project description:A well-established agenda on the research output, impact, and structure of global scientific elites such as Nobel Prize laureates has generated interest in the scientific elites from developing countries. However, this topic has not been investigated in detail. This study, first, deploys science mapping techniques to provide a comprehensive analysis of the output, impact, and structure of the Colombian scientific elite, i.e., researchers awarded with the Alejandro Ángel Escobar Foundation National Prize 1990-2020, known locally as the Colombian Nobel. Second, we conducted a productivity and impact comparison between the Colombian scientific elite and Nobel Prize laureates in science and economics by means of a stratified random sample 1990-2020 via the composite citation indicator proposed by Ioannidis et al. Findings showed that the Colombian scientific elite has a broader agenda than indexing titles in internationally renowned bibliographic databases. The Colombian scientific elite also showed positive growth, which is an inverse trend compared with the sample of Nobel laureate productivity. There were no noticeable changes in productivity/impact before and after receiving the Alejandro Ángel Escobar Foundation National Prize. Institutional collaboration within the Colombian scientific elite displayed the highest betweenness (brokerage) role of world/local top-tier universities. However, only two Colombian scientific elite members published an article with two Nobel Prize laureates. Most of the research profiles reflected the national output priorities, but were found to diverge from the national focus in respect of strategic research capacities. The interleaving of the Colombian scientific elite and Nobel Prize laureates-particularly between the 3rd and 2nd quartiles-enabled a more nuanced analysis of the local impact in the global scientific landscape. Our findings also contrast with previous findings on the lower research impact of authors from Latin America, despite their involvement as contributors to reputable journals, and also shed light on the research performance-impact standards and agenda between the global North and South and provide an in-context assessment of outstanding local research.

Dataset Information

Immune checkpoint inhibitors win the 2018 Nobel Prize.

Publications

Immune checkpoint inhibitors win the 2018 Nobel Prize.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets